- Home
- CDNA
CDNA
CareDx Inc.
as of 12-12-2025 3:58pm EST
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | 712.2M | IPO Year: | 2014 |
| Target Price: | $26.00 | AVG Volume (30 days): | 816.3K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.96 - $25.95 | Next Earning Date: | 11-04-2025 |
| Revenue: | $357,998,000 | Revenue Growth: | 14.46% |
| Revenue Growth (this year): | 14.11% | Revenue Growth (next year): | 12.00% |
AI-Powered CDNA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of CareDx Inc. (CDNA)
Secretary and General Counsel
Avg Cost/Share
$19.45
Shares
7,293
Total Value
$139,804.38
Owned After
98,211
Secretary and General Counsel
Avg Cost/Share
$15.52
Shares
2,688
Total Value
$41,722.87
Owned After
98,211
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Novack Jeffrey Adam | CDNA | Secretary and General Counsel | Dec 4, 2025 | Sell | $19.45 | 7,293 | $139,804.38 | 98,211 | |
| Novack Jeffrey Adam | CDNA | Secretary and General Counsel | Nov 7, 2025 | Sell | $15.52 | 2,688 | $41,722.87 | 98,211 |
Compare CDNA vs Leading Stocks
See how CDNA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CDNA CareDx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.